Pub Date : 2025-12-30eCollection Date: 2025-01-01DOI: 10.1155/ogi/1745668
Reva Mosleh, Jana Kassir, Hiba Assi, Hassan Ajami, Joseph Azoury, Roula Ajrouche, Amal Al-Hajje
Background: Infertility is a significant global challenge, impacting millions of individuals across the world. In Lebanon, where fertility rates are declining, understanding the knowledge, attitudes, and practices of women experiencing infertility is vital to dispelling misconceptions, improving healthcare, and offering better support for those struggling to conceive.
Methods: A cross-sectional study was conducted between June and September 2024, involving 346 Lebanese women from two fertility centers in Beirut. Participants were randomly selected to complete the questionnaire through individual interviews. Descriptive and bivariate analyses were performed, and generalized linear models were used to explore the influencing factors for each of the knowledge, attitudes, and practice scores.
Results: The results showed that 63.6% of participants had high knowledge, 66.2% had positive attitudes, and 82.1% exhibited good practices. The generalized linear models revealed that being a healthcare provider (β = 0.663), sleeping ≥ 7 h (β = 0.409), and having a history of anxiety (β = 1.258) were associated with higher knowledge scores, while advanced female age as a cause of infertility was linked to lower knowledge (β = -0.997). For attitudes, medical insurance (β = -1.312) and a family income of 1000-2000 USD (β = -2.85) improved attitudes, while smoking (β = 3.874), history of endometrial ablation (β = 5.506), and longer marriage duration (β = 0.135) worsened them. For practices, longer marriage duration (β = 0.012) and a previous assisted reproductive technology (ART) experience (β = 0.154) improved practices, while having a history of respiratory disorder (β = -0.472) decreased practice scores.
Conclusion: This study shows that Lebanese women experiencing difficulty conceiving generally have a high level of knowledge, positive attitudes, alongside good related practices toward infertility. However, knowledge gaps and cultural factors remain, highlighting the need for enhanced reproductive health education and specialized trainings for healthcare providers.
{"title":"Knowledge, Attitudes, and Practices Regarding Infertility Among Lebanese Women Experiencing Difficulty Conceiving.","authors":"Reva Mosleh, Jana Kassir, Hiba Assi, Hassan Ajami, Joseph Azoury, Roula Ajrouche, Amal Al-Hajje","doi":"10.1155/ogi/1745668","DOIUrl":"10.1155/ogi/1745668","url":null,"abstract":"<p><strong>Background: </strong>Infertility is a significant global challenge, impacting millions of individuals across the world. In Lebanon, where fertility rates are declining, understanding the knowledge, attitudes, and practices of women experiencing infertility is vital to dispelling misconceptions, improving healthcare, and offering better support for those struggling to conceive.</p><p><strong>Methods: </strong>A cross-sectional study was conducted between June and September 2024, involving 346 Lebanese women from two fertility centers in Beirut. Participants were randomly selected to complete the questionnaire through individual interviews. Descriptive and bivariate analyses were performed, and generalized linear models were used to explore the influencing factors for each of the knowledge, attitudes, and practice scores.</p><p><strong>Results: </strong>The results showed that 63.6% of participants had high knowledge, 66.2% had positive attitudes, and 82.1% exhibited good practices. The generalized linear models revealed that being a healthcare provider (<i>β</i> = 0.663), sleeping ≥ 7 h (<i>β</i> = 0.409), and having a history of anxiety (<i>β</i> = 1.258) were associated with higher knowledge scores, while advanced female age as a cause of infertility was linked to lower knowledge (<i>β</i> = -0.997). For attitudes, medical insurance (<i>β</i> = -1.312) and a family income of 1000-2000 USD (<i>β</i> = -2.85) improved attitudes, while smoking (<i>β</i> = 3.874), history of endometrial ablation (<i>β</i> = 5.506), and longer marriage duration (<i>β</i> = 0.135) worsened them. For practices, longer marriage duration (<i>β</i> = 0.012) and a previous assisted reproductive technology (ART) experience (<i>β</i> = 0.154) improved practices, while having a history of respiratory disorder (<i>β</i> = -0.472) decreased practice scores.</p><p><strong>Conclusion: </strong>This study shows that Lebanese women experiencing difficulty conceiving generally have a high level of knowledge, positive attitudes, alongside good related practices toward infertility. However, knowledge gaps and cultural factors remain, highlighting the need for enhanced reproductive health education and specialized trainings for healthcare providers.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"1745668"},"PeriodicalIF":1.3,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-30eCollection Date: 2025-01-01DOI: 10.1155/ogi/6344708
Tal Drozdovsky, Man Ho Kwok, Elena Greco
Placenta accreta spectrum (PAS) disorders involve abnormal placental invasion into the uterine wall and neighbouring organs, posing life-threatening risks during and after labour. Catastrophic obstetric haemorrhage remains the main morbidity factor, potentially leading to severe complications, including coagulopathy, acute respiratory distress, cardiac arrest, and, in some cases, death. The traditional, nonconservative approach, caesarean hysterectomy, is widely adopted for managing PAS, but it permanently eliminates fertility and carries a high risk of complications. In response, conservative management methods, such as the expectant approach, one-step conservative surgery and the Triple P procedure, have been developed to address the desire for fertility preservation and reduce surgical complications. Due to limited data in the field, current guidelines do not offer definitive recommendations for the most appropriate management approach in specific clinical situations. Therefore, the management of PAS disorders requires an individualised approach based on various factors, such as the extent of placental invasion, topography, ability to achieve haemostatic control, the patient's desire for future fertility, and the available medical resources and surgical expertise. The current literature review explores the efficacy and safety of both nonconservative and conservative management strategies, highlighting their impacts on maternal and neonatal outcomes, surgical morbidity and future fertility potential.
{"title":"Nonconservative vs. Conservative Management of Antenatally Diagnosed Placenta Accreta Spectrum Disorders: A Literature Review of Approaches and Outcomes.","authors":"Tal Drozdovsky, Man Ho Kwok, Elena Greco","doi":"10.1155/ogi/6344708","DOIUrl":"10.1155/ogi/6344708","url":null,"abstract":"<p><p>Placenta accreta spectrum (PAS) disorders involve abnormal placental invasion into the uterine wall and neighbouring organs, posing life-threatening risks during and after labour. Catastrophic obstetric haemorrhage remains the main morbidity factor, potentially leading to severe complications, including coagulopathy, acute respiratory distress, cardiac arrest, and, in some cases, death. The traditional, nonconservative approach, caesarean hysterectomy, is widely adopted for managing PAS, but it permanently eliminates fertility and carries a high risk of complications. In response, conservative management methods, such as the expectant approach, one-step conservative surgery and the Triple P procedure, have been developed to address the desire for fertility preservation and reduce surgical complications. Due to limited data in the field, current guidelines do not offer definitive recommendations for the most appropriate management approach in specific clinical situations. Therefore, the management of PAS disorders requires an individualised approach based on various factors, such as the extent of placental invasion, topography, ability to achieve haemostatic control, the patient's desire for future fertility, and the available medical resources and surgical expertise. The current literature review explores the efficacy and safety of both nonconservative and conservative management strategies, highlighting their impacts on maternal and neonatal outcomes, surgical morbidity and future fertility potential.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"6344708"},"PeriodicalIF":1.3,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767438/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-28eCollection Date: 2025-01-01DOI: 10.1155/ogi/8841801
Zainab Abdul Ameer Jaafar, Nawal Aziz Bakir, Dina Akeel Salman
Background: Biotin (vitamin B7) has been identified as an essential cofactor within metabolism and gene expression. The purpose of this study is to evaluate the level of biotin within serum and follicular fluid aspirates among infertile women undergoing IVF cycles and to compare these levels with ovulation sensitivity and rates of pregnancy.
Methods: In this observational study with 50 patients with infertility receiving intracytoplasmic sperm injection (ICSI) treatment, women were classified according to ovarian responsiveness to anti-Mullerian hormone (AMH) levels and the number of retrieved eggs. At the time of egg retrieval, the levels of biotin in the blood and the ovarian fluid were tested. The study maintained strict reporting according to the STROBE criteria.
Results: There was no significant difference with respect to either serum levels or follicular fluids' biotin among normal responders, poor responders, and hyperresponders. In contrast, there was an inverse correlation between the values of follicular biotin and AMH (p = 0.033) and BMI (p = 0.022). The data revealed that higher numbers of total and mature oocytes had significant influences on the outcome of pregnancies (p = 0.032 and p = 0.014), respectively; however, higher values of either serum fluids' biotin or follicular fluids' biotin had no significant effect.
Conclusion: Concentrations in serum and follicular fluid of biotin do not play any role in IVF outcome. The negative correlation with AMH and BMI levels might indicate the role of biotin in the ovaries as an indicator of ovarian metabolism. The result provides valuable data in understanding the possible role of biotin in the microenvironment of the ovaries and the need to study it further.
{"title":"Associations of Biotin Levels in Serum and Follicular Fluid With ICSI Success: A Cross-Sectional Study From Iraq.","authors":"Zainab Abdul Ameer Jaafar, Nawal Aziz Bakir, Dina Akeel Salman","doi":"10.1155/ogi/8841801","DOIUrl":"10.1155/ogi/8841801","url":null,"abstract":"<p><strong>Background: </strong>Biotin (vitamin B7) has been identified as an essential cofactor within metabolism and gene expression. The purpose of this study is to evaluate the level of biotin within serum and follicular fluid aspirates among infertile women undergoing IVF cycles and to compare these levels with ovulation sensitivity and rates of pregnancy.</p><p><strong>Methods: </strong>In this observational study with 50 patients with infertility receiving intracytoplasmic sperm injection (ICSI) treatment, women were classified according to ovarian responsiveness to anti-Mullerian hormone (AMH) levels and the number of retrieved eggs. At the time of egg retrieval, the levels of biotin in the blood and the ovarian fluid were tested. The study maintained strict reporting according to the STROBE criteria.</p><p><strong>Results: </strong>There was no significant difference with respect to either serum levels or follicular fluids' biotin among normal responders, poor responders, and hyperresponders. In contrast, there was an inverse correlation between the values of follicular biotin and AMH (<i>p</i> = 0.033) and BMI (<i>p</i> = 0.022). The data revealed that higher numbers of total and mature oocytes had significant influences on the outcome of pregnancies (<i>p</i> = 0.032 and <i>p</i> = 0.014), respectively; however, higher values of either serum fluids' biotin or follicular fluids' biotin had no significant effect.</p><p><strong>Conclusion: </strong>Concentrations in serum and follicular fluid of biotin do not play any role in IVF outcome. The negative correlation with AMH and BMI levels might indicate the role of biotin in the ovaries as an indicator of ovarian metabolism. The result provides valuable data in understanding the possible role of biotin in the microenvironment of the ovaries and the need to study it further.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"8841801"},"PeriodicalIF":1.3,"publicationDate":"2025-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-23eCollection Date: 2025-01-01DOI: 10.1155/ogi/5797924
Sisay Kirba, Abdulfetah Abdulkedir Abdosh, Ekram Muhammedasrar, Abraham Fessehaye Sium
Background: Currently, the World Health Organization guidelines recommend universal utilization of optimally timed first obstetric ultrasound (defined as ultrasound before 24 weeks) in low-middle income countries. However, there is inadequate evidence on this topic from these countries. Our study aimed to determine the rate of utilization of optimally timed first obstetric ultrasound among pregnant women who gave birth at three public hospitals in Ethiopia.
Methods: This was a multicenter prospective cross-sectional study conducted on the utilization of optimally timed first obstetric ultrasound among pregnant women who delivered at public hospitals in Ethiopia in 2020. Data were collected prospectively using a structured questionnaire. Data were analyzed using SPSS Version 20. Simple descriptive statistics, chi-squared test, and multiple regression analysis were performed as appropriate. p value less than 0.05 and adjusted odds ratio (AOR) with 95% CI were used to present result significance.
Results: A total of 385 participants were included in this study. Approximately 67.5% of pregnant mothers had optimally timed 1st ultrasound. Compared to those having antenatal care (ANC) at health centers, those who started their ANC at private clinic were 1.7 times (95 CI: 1.8-7.9) more likely to have optimally timed ANC. Those who had their 1st ANC at private hospital were 3.2 times (95 CI: 1.8-7.9) more likely to have optimally timed 1st prenatal care. Those who had their first ANC at private health institutions and government hospitals were much more likely to have optimally timed 1st prenatal ultrasound with the following AOR for government hospital and private MCH centers: AOR = 7.4 (95 CI: 2.7-23) and AOR = 4.9 (95 CI: 2.8-14.1), respectively. Those who had previous major obstetric problem were 5.2 times (95 CI: 2.7-9.9) more likely to have optimally timed ultrasound than those without major previous obstetric problem.
Conclusion: We found that one-third of pregnant women did not utilize optimally timed first obstetric ultrasound, despite obstetric ultrasound services being accessible at public health institutions. Place of first ANC contact and presence of prior major obstetric complication were associated with utilization of optimally dated first obstetric ultrasound.
{"title":"Universal Utilization of Optimally Timed First Obstetric Ultrasound Among Pregnant Women in a Low-Middle Income Country: A Multicenter Prospective Study.","authors":"Sisay Kirba, Abdulfetah Abdulkedir Abdosh, Ekram Muhammedasrar, Abraham Fessehaye Sium","doi":"10.1155/ogi/5797924","DOIUrl":"10.1155/ogi/5797924","url":null,"abstract":"<p><strong>Background: </strong>Currently, the World Health Organization guidelines recommend universal utilization of optimally timed first obstetric ultrasound (defined as ultrasound before 24 weeks) in low-middle income countries. However, there is inadequate evidence on this topic from these countries. Our study aimed to determine the rate of utilization of optimally timed first obstetric ultrasound among pregnant women who gave birth at three public hospitals in Ethiopia.</p><p><strong>Methods: </strong>This was a multicenter prospective cross-sectional study conducted on the utilization of optimally timed first obstetric ultrasound among pregnant women who delivered at public hospitals in Ethiopia in 2020. Data were collected prospectively using a structured questionnaire. Data were analyzed using SPSS Version 20. Simple descriptive statistics, chi-squared test, and multiple regression analysis were performed as appropriate. <i>p</i> value less than 0.05 and adjusted odds ratio (AOR) with 95% CI were used to present result significance.</p><p><strong>Results: </strong>A total of 385 participants were included in this study. Approximately 67.5% of pregnant mothers had optimally timed 1<sup>st</sup> ultrasound. Compared to those having antenatal care (ANC) at health centers, those who started their ANC at private clinic were 1.7 times (95 CI: 1.8-7.9) more likely to have optimally timed ANC. Those who had their 1<sup>st</sup> ANC at private hospital were 3.2 times (95 CI: 1.8-7.9) more likely to have optimally timed 1<sup>st</sup> prenatal care. Those who had their first ANC at private health institutions and government hospitals were much more likely to have optimally timed 1<sup>st</sup> prenatal ultrasound with the following AOR for government hospital and private MCH centers: AOR = 7.4 (95 CI: 2.7-23) and AOR = 4.9 (95 CI: 2.8-14.1), respectively. Those who had previous major obstetric problem were 5.2 times (95 CI: 2.7-9.9) more likely to have optimally timed ultrasound than those without major previous obstetric problem.</p><p><strong>Conclusion: </strong>We found that one-third of pregnant women did not utilize optimally timed first obstetric ultrasound, despite obstetric ultrasound services being accessible at public health institutions. Place of first ANC contact and presence of prior major obstetric complication were associated with utilization of optimally dated first obstetric ultrasound.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"5797924"},"PeriodicalIF":1.3,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-22eCollection Date: 2025-01-01DOI: 10.1155/ogi/4476955
Sadia Fatema Kabir, Muhammad Ashik-Ur-Rahman, Abdur Rahman, Md Afzal Hossen, Rowfun Rahman, Farhana Huq, Mohibbul Haque, Junnatul Fardous Marfi, Md Abdullah Saeed Khan, Mohammad Delwer Hossain Hawlader
Background: Despite its availability, cervical cancer screening services continue to remain underutilized in many regions. This study aimed to assess the prevalence and determinants of cervical cancer screening uptake among women in the north-central area of Bangladesh.
Methods: In this cross-sectional study, between May and October 2022, women aged 30-60 years attending a tertiary care hospital in Gazipur district were approached for inclusion. Face-to-face interviews were conducted using a semistructured questionnaire. A total of 252 women were consecutively recruited within the study period. The self-reported screening practice was recorded and verified by matching with identification numbers provided for screening by the hospital, and reasons for nonutilization were also collected.
Results: Only 12 women (4.76%) had ever been screened for cervical cancer. Lower knowledge scores (OR: 0.26 and 95% CI: 0.08-0.95) were associated with higher odds of nonutilization of cervical cancer screening services on multivariable analysis. Despite high awareness of symptoms and risk factors, only 15.08% knew that screening prevents cancer. The main reasons for not getting screened were fear of pain (98.33%) and feeling shy (52.50%).
Conclusion: Awareness-increasing programs are recommended to improve the utilization of cervical cancer screening among women.
{"title":"Factors Associated With Low Utilization of Cervical Cancer Screening Services in Gazipur, Bangladesh.","authors":"Sadia Fatema Kabir, Muhammad Ashik-Ur-Rahman, Abdur Rahman, Md Afzal Hossen, Rowfun Rahman, Farhana Huq, Mohibbul Haque, Junnatul Fardous Marfi, Md Abdullah Saeed Khan, Mohammad Delwer Hossain Hawlader","doi":"10.1155/ogi/4476955","DOIUrl":"10.1155/ogi/4476955","url":null,"abstract":"<p><strong>Background: </strong>Despite its availability, cervical cancer screening services continue to remain underutilized in many regions. This study aimed to assess the prevalence and determinants of cervical cancer screening uptake among women in the north-central area of Bangladesh.</p><p><strong>Methods: </strong>In this cross-sectional study, between May and October 2022, women aged 30-60 years attending a tertiary care hospital in Gazipur district were approached for inclusion. Face-to-face interviews were conducted using a semistructured questionnaire. A total of 252 women were consecutively recruited within the study period. The self-reported screening practice was recorded and verified by matching with identification numbers provided for screening by the hospital, and reasons for nonutilization were also collected.</p><p><strong>Results: </strong>Only 12 women (4.76%) had ever been screened for cervical cancer. Lower knowledge scores (OR: 0.26 and 95% CI: 0.08-0.95) were associated with higher odds of nonutilization of cervical cancer screening services on multivariable analysis. Despite high awareness of symptoms and risk factors, only 15.08% knew that screening prevents cancer. The main reasons for not getting screened were fear of pain (98.33%) and feeling shy (52.50%).</p><p><strong>Conclusion: </strong>Awareness-increasing programs are recommended to improve the utilization of cervical cancer screening among women.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"4476955"},"PeriodicalIF":1.3,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: This study aimed to evaluate the adverse maternal and neonatal outcomes among pregnant women with COVID-19 at King Salman Armed Forces Hospital in Tabuk and examine the relationship between the severity of COVID-19 infection and these outcomes.
Methods: This retrospective cohort study enrolled COVID-19-positive pregnant women. Demographic and obstetric information, clinical characteristics (including symptoms and preexisting comorbid conditions), and maternal and neonatal outcomes were collected from medical records, reviewed, and analyzed.
Results: The study included 138 COVID-19-positive women, with the majority of cases diagnosed in the third trimester (85.5%). Assessment of the severity of COVID-19 infection showed that a large proportion were asymptomatic (39.1%) or had mild disease (39.9%), while 14.5% had moderate disease and 6.5% experienced severe illness. Adverse maternal and neonatal outcomes included preeclampsia (5.1%), gestational diabetes (4.3%), placental abruption, premature rupture of membranes (2.9% each), maternal intensive care unit (ICU) admission (1.4%), preterm births (12.3%), low birth weight (15.2%), and neonatal ICU admission (10.1%). Additionally, the incidences of preeclampsia and maternal ICU admission were significantly higher in women with severe COVID-19 compared to those with milder or asymptomatic cases (p = 0.004 each). Neonatal ICU admission showed the highest incidence (33.3%) among severe cases (p = 0.031). Asthma was significantly linked to a higher risk of neonatal ICU admission (23.1% vs. 7.1%). Diabetes mellitus was associated with an increased rate of maternal ICU admission (13.3% vs. 0%). Hypertension showed significant associations with elevated rates of preeclampsia (35.7% vs. 1.6%), maternal ICU admission (14.3% vs. 0%), and neonatal ICU admission (35.7% vs. 7.3%).
Conclusion: COVID-19 infection during pregnancy was associated with several adverse maternal and neonatal outcomes, including preeclampsia, gestational diabetes, preterm birth, low birth weight, and increased ICU admissions. Severe maternal disease and existing comorbidities further elevated the risks of complications for both mother and newborn.
{"title":"Retrospective Cohort Study of Pregnancy Maternal Outcomes of Women With COVID-19 in King Salman Armed Forces Hospital, Tabuk, Kingdom of Saudi Arabia.","authors":"Abdulrahman Wasel Koja, Rofayda Mansour Ahmed Mohamad, Mubarak Saleh Almarjan, Mayar Hamed Albakri","doi":"10.1155/ogi/3287655","DOIUrl":"10.1155/ogi/3287655","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to evaluate the adverse maternal and neonatal outcomes among pregnant women with COVID-19 at King Salman Armed Forces Hospital in Tabuk and examine the relationship between the severity of COVID-19 infection and these outcomes.</p><p><strong>Methods: </strong>This retrospective cohort study enrolled COVID-19-positive pregnant women. Demographic and obstetric information, clinical characteristics (including symptoms and preexisting comorbid conditions), and maternal and neonatal outcomes were collected from medical records, reviewed, and analyzed.</p><p><strong>Results: </strong>The study included 138 COVID-19-positive women, with the majority of cases diagnosed in the third trimester (85.5%). Assessment of the severity of COVID-19 infection showed that a large proportion were asymptomatic (39.1%) or had mild disease (39.9%), while 14.5% had moderate disease and 6.5% experienced severe illness. Adverse maternal and neonatal outcomes included preeclampsia (5.1%), gestational diabetes (4.3%), placental abruption, premature rupture of membranes (2.9% each), maternal intensive care unit (ICU) admission (1.4%), preterm births (12.3%), low birth weight (15.2%), and neonatal ICU admission (10.1%). Additionally, the incidences of preeclampsia and maternal ICU admission were significantly higher in women with severe COVID-19 compared to those with milder or asymptomatic cases (<i>p</i> = 0.004 each). Neonatal ICU admission showed the highest incidence (33.3%) among severe cases (<i>p</i> = 0.031). Asthma was significantly linked to a higher risk of neonatal ICU admission (23.1% vs. 7.1%). Diabetes mellitus was associated with an increased rate of maternal ICU admission (13.3% vs. 0%). Hypertension showed significant associations with elevated rates of preeclampsia (35.7% vs. 1.6%), maternal ICU admission (14.3% vs. 0%), and neonatal ICU admission (35.7% vs. 7.3%).</p><p><strong>Conclusion: </strong>COVID-19 infection during pregnancy was associated with several adverse maternal and neonatal outcomes, including preeclampsia, gestational diabetes, preterm birth, low birth weight, and increased ICU admissions. Severe maternal disease and existing comorbidities further elevated the risks of complications for both mother and newborn.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"3287655"},"PeriodicalIF":1.3,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: To validate previous age subgrouping methods and provide an optimal age reference for women planning to delay in vitro fertilization (IVF).
Methods: From July 2014 to March 2018, 3012 patients that received IVF/intracytoplasmic sperm injection (ICSI) were continuously recruited in this retrospective, single-center study. We analyzed the relationships of baseline characteristics and IVF outcomes. A smooth fitting curve depicting the association of age and live birth was plotted using the generalized additive model (GAM) method. We also evaluated the association of age and live birth among different age groups (> 20, ≤ 35; > 35, ≤ 37; > 37, ≤ 40; and > 40).
Results: Age, duration of infertility, and baseline follicle-stimulating hormone (FSH) were significantly related to the live birth rate. The adjusted Odd Ratio (OR) value of age was 0.95 (P < 0.001), indicating the higher occurrence of no live birth with age increasing. The fitting curve showed that the live birth rate decreased with age. And 35.5 (34.5-36.5) was identified as the inflection point of the curve. The slopes before 35.5 and after 35.5 were significantly different (0.9 [0.9, 1.0], P < 0.001). When ≤ 35, live birth rate did not vary with age. For the ages of 35-37 and 37-40, the occurrence of negative outcome increased with age (aOR: 0.73 [0.53, 0.99], 0.80 [0.65, 1.00]; P = 0.0441, 0.0465, respectively).
Conclusion: The age of 35 can be referred to as the safe time point when the IVF success rate does not decline with age. And the risk of IVF failure increases rapidly in the period of 35-37 and 37-40.
{"title":"When to Choose In Vitro Fertilization (IVF) When Postponing Conceiving: The Age-Related Risk of IVF Failure at an Advanced Age.","authors":"Zhiyan Chen, Duoduo Zhang, Zhengyi Sun, Qi Yu, Chenyang Zhao, ChangZhong Li","doi":"10.1155/ogi/2407539","DOIUrl":"10.1155/ogi/2407539","url":null,"abstract":"<p><strong>Background: </strong>To validate previous age subgrouping methods and provide an optimal age reference for women planning to delay in vitro fertilization (IVF).</p><p><strong>Methods: </strong>From July 2014 to March 2018, 3012 patients that received IVF/intracytoplasmic sperm injection (ICSI) were continuously recruited in this retrospective, single-center study. We analyzed the relationships of baseline characteristics and IVF outcomes. A smooth fitting curve depicting the association of age and live birth was plotted using the generalized additive model (GAM) method. We also evaluated the association of age and live birth among different age groups (> 20, ≤ 35; > 35, ≤ 37; > 37, ≤ 40; and > 40).</p><p><strong>Results: </strong>Age, duration of infertility, and baseline follicle-stimulating hormone (FSH) were significantly related to the live birth rate. The adjusted Odd Ratio (OR) value of age was 0.95 (<i>P</i> < 0.001), indicating the higher occurrence of no live birth with age increasing. The fitting curve showed that the live birth rate decreased with age. And 35.5 (34.5-36.5) was identified as the inflection point of the curve. The slopes before 35.5 and after 35.5 were significantly different (0.9 [0.9, 1.0], <i>P</i> < 0.001). When ≤ 35, live birth rate did not vary with age. For the ages of 35-37 and 37-40, the occurrence of negative outcome increased with age (aOR: 0.73 [0.53, 0.99], 0.80 [0.65, 1.00]; <i>P</i> = 0.0441, 0.0465, respectively).</p><p><strong>Conclusion: </strong>The age of 35 can be referred to as the safe time point when the IVF success rate does not decline with age. And the risk of IVF failure increases rapidly in the period of 35-37 and 37-40.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"2407539"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08eCollection Date: 2025-01-01DOI: 10.1155/ogi/3096143
Riko Araki, Masahito Hitosugi, Kentaro Takahashi
Background: No studies have effectively clarified the relationship between uterine contractions and the act of acceleration or driving behaviors in pregnant women.
Aims: To confirm the effect of driving a motor vehicle on physiological changes in pregnant women, we examined uterine contractions while driving.
Materials and methods: Seventeen pregnant women with a gestational age of 30-35 weeks were enrolled in this study. Uterine contractions were monitored remotely using a mobile delivery monitoring device. Triaxial acceleration of the vehicle, vehicle velocity, and vehicle kinematics were monitored using a driving recorder.
Results: The average number of uterine contractions per 30 min in all participants was 1.0 (range, 0.26-2.0). When comparing the median vehicle velocity during a uterine contraction with that when there were no contractions, no significant difference was found (23 km/hour vs. 31 km/hour, p = 0.36). The prevalence of low velocity (20 km/hour or less) was significantly higher, and that of higher velocity (50 km/hour or more) was lower during a uterine contraction than with no contractions (p = 0.023 and 0.012, respectively). When comparing resultant vehicle acceleration, no significant differences were found between women with uterine contractions and those with no contractions. The distributions were similar before and immediately before a uterine contraction and with no contractions.
Conclusions: Driving a motor vehicle should be considered a normal activity of daily life in pregnant women and seems unlikely to predispose to preterm birth.
背景:目前尚无研究有效阐明孕妇子宫收缩与加速行为或驾驶行为之间的关系。目的:为了确认驾驶机动车对孕妇生理变化的影响,我们检测了驾车时子宫收缩。材料与方法:17例孕周30-35周的孕妇入选本研究。使用移动分娩监测装置远程监测子宫收缩。使用驾驶记录仪监测车辆的三轴加速度、车辆速度和车辆运动学。结果:所有参与者平均每30分钟子宫收缩次数为1.0次(范围0.26-2.0)。子宫收缩时与无宫缩时的车速中位数比较,差异无统计学意义(23 km/h vs 31 km/h, p = 0.36)。子宫收缩时低速(20km /h以下)的发生率显著高于无宫缩时,高速(50km /h以上)的发生率显著低于无宫缩时(p = 0.023和0.012)。当比较由此产生的车辆加速度时,在子宫收缩的妇女和没有子宫收缩的妇女之间没有发现显著差异。子宫收缩前、紧接前和无宫缩时的分布相似。结论:驾驶机动车应被视为孕妇日常生活的正常活动,似乎不太可能导致早产。
{"title":"Motor Vehicle Driving During Pregnancy Does Not Influence Uterine Contractions.","authors":"Riko Araki, Masahito Hitosugi, Kentaro Takahashi","doi":"10.1155/ogi/3096143","DOIUrl":"10.1155/ogi/3096143","url":null,"abstract":"<p><strong>Background: </strong>No studies have effectively clarified the relationship between uterine contractions and the act of acceleration or driving behaviors in pregnant women.</p><p><strong>Aims: </strong>To confirm the effect of driving a motor vehicle on physiological changes in pregnant women, we examined uterine contractions while driving.</p><p><strong>Materials and methods: </strong>Seventeen pregnant women with a gestational age of 30-35 weeks were enrolled in this study. Uterine contractions were monitored remotely using a mobile delivery monitoring device. Triaxial acceleration of the vehicle, vehicle velocity, and vehicle kinematics were monitored using a driving recorder.</p><p><strong>Results: </strong>The average number of uterine contractions per 30 min in all participants was 1.0 (range, 0.26-2.0). When comparing the median vehicle velocity during a uterine contraction with that when there were no contractions, no significant difference was found (23 km/hour vs. 31 km/hour, <i>p</i> = 0.36). The prevalence of low velocity (20 km/hour or less) was significantly higher, and that of higher velocity (50 km/hour or more) was lower during a uterine contraction than with no contractions (<i>p</i> = 0.023 and 0.012, respectively). When comparing resultant vehicle acceleration, no significant differences were found between women with uterine contractions and those with no contractions. The distributions were similar before and immediately before a uterine contraction and with no contractions.</p><p><strong>Conclusions: </strong>Driving a motor vehicle should be considered a normal activity of daily life in pregnant women and seems unlikely to predispose to preterm birth.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"3096143"},"PeriodicalIF":1.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-10eCollection Date: 2025-01-01DOI: 10.1155/ogi/5544073
Zeyad Mohammed Abualiat, Joud Sami Makki, Shahad Mubarak Aljebeli, Rawan Othman Bamousa, Orjowan Zuhair Alamri, Alwaten Fahad Alabdullah, Haya Al Fozan
<p><strong>Objectives: </strong>The primary objective of the study is to compare the rate of pregnancy and live birth rate in infertile couples with nonobstructive azoospermia (NOA) treated with either fresh or frozen sperms in intracytoplasmic sperm injection (ICSI) cycles. It is already known that the use of frozen sperm in ICSI cycles is considered favorable and is reported to have no significant difference in outcomes when compared to fresh sperm. However, there is still an ongoing debate about the superiority of fresh or frozen-thawed spermatozoa in men with NOA, particularly in the context of Saudi Arabia where this subject has not been previously investigated.</p><p><strong>Design: </strong>This retrospective cohort study was conducted at the in vitro fertilization (IVF) unit at KAMC-R, Ministry of National Guard Hospital Affairs (MNGHA) in Riyadh, Saudi Arabia. It includes couples who underwent ICSI cycles throughout four years (2019-2022), provided that they had no female infertility causes. A checklist was prepared to collect data from patients' medical records.</p><p><strong>Participants setting and methods: </strong>This retrospective cohort study analyzed data from 230 infertile couples who underwent ICSI cycles between 2019 and 2022. We compared pregnancy, live birth, and overall success rates in cycles using fresh versus frozen-thawed testicular sperm, controlling for factors like age, infertility type, and hormone levels. Statistical analysis included chi-square tests, Fisher's exact tests, Student's <i>t</i> tests, and Mann-Whitney tests to compare outcomes between groups.</p><p><strong>Results: </strong>A total of 231 women were included. Their mean ± standard deviation (SD) age was 31.5 ± 5.4. Almost two-thirds (67.5%) had primary infertility. Regarding the type of sperms used in intracytoplasmic sperm injection, fresh sperms represented 57.1%, while the remaining 42.9% were frozen sperms. Rates of pregnancy, live births, ectopic pregnancy, and abortion were 32.5%, 23.5%, 3.5%, and 5.7%, respectively. Overall, the success rate of ICSI was 29.8%. The pregnancy rate was significantly higher using fresh spermatozoa in ICSI than frozen spermatozoa (37.9% vs. 25.3%), <i>p</i>=0.043. Similarly, live births and overall successful outcome rates of using fresh spermatozoa in ICSI were significantly higher than those of frozen spermatozoa (28.8% and 34.8% vs. 16% and 22.6%), <i>p</i>=0.025 and 0.048, respectively.</p><p><strong>Limitations: </strong>The study demonstrated an association between fresh sperm use and higher success rates, but it did not prove causality.</p><p><strong>Conclusion: </strong>When both fresh and frozen sperm were used, the rates of pregnancy, live birth, and overall success in ICSI were higher in fresh sperm. Additionally, younger males and females showed a greater likelihood of successful ICSI outcomes. There is a potential benefit of using fresh sperm in ICSI for this specific patient group but highlights the
目的:本研究的主要目的是比较在卵胞浆内单精子注射(ICSI)周期中使用新鲜或冷冻精子治疗非阻塞性无精子症(NOA)的不孕夫妇的妊娠率和活产率。众所周知,在ICSI周期中使用冷冻精子被认为是有利的,据报道,与新鲜精子相比,冷冻精子的结果没有显著差异。然而,关于新鲜或冷冻解冻精子对NOA男性的优势仍存在争议,特别是在沙特阿拉伯的背景下,这个问题以前没有进行过调查。设计:本回顾性队列研究在沙特阿拉伯利雅得国民警卫队医院事务部(MNGHA) KAMC-R的体外受精(IVF)部门进行。它包括在四年内(2019-2022年)进行ICSI周期的夫妇,前提是他们没有女性不育的原因。准备了一份清单,从病人的医疗记录中收集数据。参与者设置和方法:这项回顾性队列研究分析了2019年至2022年间接受ICSI周期的230对不孕夫妇的数据。在控制年龄、不育类型和激素水平等因素的情况下,我们比较了使用新鲜睾丸精子和冷冻解冻睾丸精子的怀孕、活产和总成功率。统计分析包括卡方检验、Fisher精确检验、学生t检验和Mann-Whitney检验来比较组间结果。结果:共纳入231名女性。平均±标准差(SD)年龄为31.5±5.4岁。几乎三分之二(67.5%)为原发性不孕症。就卵胞浆内单精子注射使用的精子类型而言,新鲜精子占57.1%,其余42.9%为冷冻精子。妊娠率为32.5%,活产率为23.5%,异位妊娠率为3.5%,流产率为5.7%。总体而言,ICSI成功率为29.8%。使用新鲜精子进行ICSI的受孕率明显高于冷冻精子(37.9% vs. 25.3%), p=0.043。同样,在ICSI中使用新鲜精子的活产率和总成功率显著高于冷冻精子(28.8%和34.8% vs. 16%和22.6%),p分别=0.025和0.048。局限性:该研究证明了新鲜精子的使用与更高的成功率之间的联系,但它没有证明因果关系。结论:冷冻和新鲜精子同时使用时,新鲜精子的受孕率、活产率和ICSI的总体成功率更高。此外,年轻的男性和女性更有可能成功进行ICSI。对于这一特定的患者群体,在ICSI中使用新鲜精子有潜在的好处,但强调需要进一步的研究来巩固这些发现,并探索观察到的差异背后的原因。这项研究增加了NOA男性ICSI的知识体系,并强调需要进一步研究以完善临床实践并改善不育夫妇的结果。
{"title":"Comparison of Pregnancy Rate and Live Birth Rate of Intracytoplasmic Sperm Injection Cycles Using Fresh Versus Frozen-Thawed Testicular Sperm.","authors":"Zeyad Mohammed Abualiat, Joud Sami Makki, Shahad Mubarak Aljebeli, Rawan Othman Bamousa, Orjowan Zuhair Alamri, Alwaten Fahad Alabdullah, Haya Al Fozan","doi":"10.1155/ogi/5544073","DOIUrl":"10.1155/ogi/5544073","url":null,"abstract":"<p><strong>Objectives: </strong>The primary objective of the study is to compare the rate of pregnancy and live birth rate in infertile couples with nonobstructive azoospermia (NOA) treated with either fresh or frozen sperms in intracytoplasmic sperm injection (ICSI) cycles. It is already known that the use of frozen sperm in ICSI cycles is considered favorable and is reported to have no significant difference in outcomes when compared to fresh sperm. However, there is still an ongoing debate about the superiority of fresh or frozen-thawed spermatozoa in men with NOA, particularly in the context of Saudi Arabia where this subject has not been previously investigated.</p><p><strong>Design: </strong>This retrospective cohort study was conducted at the in vitro fertilization (IVF) unit at KAMC-R, Ministry of National Guard Hospital Affairs (MNGHA) in Riyadh, Saudi Arabia. It includes couples who underwent ICSI cycles throughout four years (2019-2022), provided that they had no female infertility causes. A checklist was prepared to collect data from patients' medical records.</p><p><strong>Participants setting and methods: </strong>This retrospective cohort study analyzed data from 230 infertile couples who underwent ICSI cycles between 2019 and 2022. We compared pregnancy, live birth, and overall success rates in cycles using fresh versus frozen-thawed testicular sperm, controlling for factors like age, infertility type, and hormone levels. Statistical analysis included chi-square tests, Fisher's exact tests, Student's <i>t</i> tests, and Mann-Whitney tests to compare outcomes between groups.</p><p><strong>Results: </strong>A total of 231 women were included. Their mean ± standard deviation (SD) age was 31.5 ± 5.4. Almost two-thirds (67.5%) had primary infertility. Regarding the type of sperms used in intracytoplasmic sperm injection, fresh sperms represented 57.1%, while the remaining 42.9% were frozen sperms. Rates of pregnancy, live births, ectopic pregnancy, and abortion were 32.5%, 23.5%, 3.5%, and 5.7%, respectively. Overall, the success rate of ICSI was 29.8%. The pregnancy rate was significantly higher using fresh spermatozoa in ICSI than frozen spermatozoa (37.9% vs. 25.3%), <i>p</i>=0.043. Similarly, live births and overall successful outcome rates of using fresh spermatozoa in ICSI were significantly higher than those of frozen spermatozoa (28.8% and 34.8% vs. 16% and 22.6%), <i>p</i>=0.025 and 0.048, respectively.</p><p><strong>Limitations: </strong>The study demonstrated an association between fresh sperm use and higher success rates, but it did not prove causality.</p><p><strong>Conclusion: </strong>When both fresh and frozen sperm were used, the rates of pregnancy, live birth, and overall success in ICSI were higher in fresh sperm. Additionally, younger males and females showed a greater likelihood of successful ICSI outcomes. There is a potential benefit of using fresh sperm in ICSI for this specific patient group but highlights the ","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"5544073"},"PeriodicalIF":1.3,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12623106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145550054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-24eCollection Date: 2025-01-01DOI: 10.1155/ogi/9983293
Luping Pan, Yuan Xiang, Jinju Guo, Wei Liu, Xia Wang
Background: This study aims to evaluate the impact of adjuvant chemotherapy on cancer-specific survival (CSS) and overall survival (OS) in patients with Stage IA ovarian clear cell carcinoma (OCCC) using data from the Surveillance, Epidemiology, and End Results (SEER) database.
Methods: We conducted a retrospective cohort study utilizing SEER data (2000-2021) to compare the prognosis of Stage IA OCCC patients who received adjuvant chemotherapy versus those who did not. Propensity score matching (PSM) was used to balance baseline characteristics between the groups. Competing risks regression and multivariate Cox regression analyses identified prognostic factors for CSS and OS.
Results: A total of 1422 Stage IA OCCC patients were identified. After PSM, 776 patients (388 in each group) were included. For patients aged ≤ 50 years, chemotherapy was linked to worse CSS (89.5% vs. 96.2%, p=0.007) and OS (89.3% vs. 95.9%, p=0.008). Conversely, in patients aged > 70 years, chemotherapy was associated with improved CSS (93.0% vs. 81.9%, p=0.038) and OS (86.0% vs. 72.4%, p=0.006). These trends remained after PSM. Multivariate analysis showed that chemotherapy had little impact on OS and CSS. Subgroup analysis further indicated that chemotherapy negatively affected CSS and OS in patients aged ≤ 50 years.
Conclusions: Adjuvant chemotherapy did not significantly improve survival outcomes in patients with Stage IA OCCC. However, its effects were age-dependent, with older patients (> 70 years) experiencing improved survival, while younger patients (≤ 50 years) exhibited worse outcomes. These findings underscore the importance of individualized treatment strategies for Stage IA OCCC.
{"title":"Divergent Survival Outcomes With Adjuvant Chemotherapy in Stage IA Ovarian Clear Cell Carcinoma: Insights From the SEER Database.","authors":"Luping Pan, Yuan Xiang, Jinju Guo, Wei Liu, Xia Wang","doi":"10.1155/ogi/9983293","DOIUrl":"10.1155/ogi/9983293","url":null,"abstract":"<p><strong>Background: </strong>This study aims to evaluate the impact of adjuvant chemotherapy on cancer-specific survival (CSS) and overall survival (OS) in patients with Stage IA ovarian clear cell carcinoma (OCCC) using data from the Surveillance, Epidemiology, and End Results (SEER) database.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study utilizing SEER data (2000-2021) to compare the prognosis of Stage IA OCCC patients who received adjuvant chemotherapy versus those who did not. Propensity score matching (PSM) was used to balance baseline characteristics between the groups. Competing risks regression and multivariate Cox regression analyses identified prognostic factors for CSS and OS.</p><p><strong>Results: </strong>A total of 1422 Stage IA OCCC patients were identified. After PSM, 776 patients (388 in each group) were included. For patients aged ≤ 50 years, chemotherapy was linked to worse CSS (89.5% vs. 96.2%, <i>p</i>=0.007) and OS (89.3% vs. 95.9%, <i>p</i>=0.008). Conversely, in patients aged > 70 years, chemotherapy was associated with improved CSS (93.0% vs. 81.9%, <i>p</i>=0.038) and OS (86.0% vs. 72.4%, <i>p</i>=0.006). These trends remained after PSM. Multivariate analysis showed that chemotherapy had little impact on OS and CSS. Subgroup analysis further indicated that chemotherapy negatively affected CSS and OS in patients aged ≤ 50 years.</p><p><strong>Conclusions: </strong>Adjuvant chemotherapy did not significantly improve survival outcomes in patients with Stage IA OCCC. However, its effects were age-dependent, with older patients (> 70 years) experiencing improved survival, while younger patients (≤ 50 years) exhibited worse outcomes. These findings underscore the importance of individualized treatment strategies for Stage IA OCCC.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"9983293"},"PeriodicalIF":1.3,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12578555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145431738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}